{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:22:45Z","timestamp":1783570965633,"version":"3.55.0"},"reference-count":14,"publisher":"Hindawi Limited","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatology Research and Practice"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. We have compared NB-UVB and oral minocycline in stabilizing vitiligo for the first time.<jats:italic>Subjects and Methods<\/jats:italic>. 42 patients were divided equally into two groups: the NB-UVB and minocycline groups. Phototherapy was administered twice a week on nonconsecutive days. In the minocycline group, patients were advised to take minocycline 100\u2009mg once daily. The treatment period was 3 months. Vitiligo disease activity (VIDA) score was noted every 4 weeks for 12 months. Digital photographs were taken at baseline and monthly intervals.<jats:italic>Results<\/jats:italic>. Before the therapy, disease activity was present in 100% of the patients, which was reduced to 23.8% and 66.1% by the end of therapy in the NB-UVB and minocycline groups retrospectively (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\"><mml:mi>P<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.05<\/mml:mn><\/mml:math>). 16 of the 21 (76\/1%) patients with unstable disease in the NB-UVB group achieved stability, whereas this was the case for only 7 of the 21 (33.3%) in the minocycline group (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\"><mml:mi>P<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.001<\/mml:mn><\/mml:math>). The diameter changes were statistically significant at the end of treatment in the NB-UVB group compared to the minocycline group (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\"><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.031<\/mml:mn><\/mml:math>). Side effects in both groups were mild.<jats:italic>Conclusion<\/jats:italic>. NB-UVB was statistically more advantageous than oral minocycline in unstable vitiligo in terms of efficacy and the resulting stability.<\/jats:p>","DOI":"10.1155\/2014\/240856","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T22:41:25Z","timestamp":1408660885000},"page":"1-4","source":"Crossref","is-referenced-by-count":21,"title":["Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial"],"prefix":"10.1155","volume":"2014","author":[{"given":"Amir Hossein","family":"Siadat","sequence":"first","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Zeinali","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Iraji","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Abtahi-Naeini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Students\u2019 Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Nilforoushzadeh","sequence":"additional","affiliation":[{"name":"Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kioumars","family":"Jamshidi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Khosravani","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"issue":"1","key":"1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1721727X0600400103","volume":"4","year":"2006","journal-title":"European Journal of Inflammation"},{"issue":"1","key":"2","first-page":"9","volume":"22","year":"2008","journal-title":"International Journal of Molecular Medicine"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1993.tb00023.x"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1532"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.2165\/11630540-000000000-00000"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02283.x"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01328.x"},{"issue":"4","key":"8","first-page":"407","volume":"135","year":"1999","journal-title":"Archives of Dermatology"},{"issue":"1","key":"9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0378-6323.125479","volume":"80","year":"2014","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10","first-page":"15","volume":"2","year":"2009","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"issue":"6","key":"11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/phpp.12072","volume":"29","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.677"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12480997"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480113020"}],"container-title":["Dermatology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/drp\/2014\/240856.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/drp\/2014\/240856.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/drp\/2014\/240856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:09:30Z","timestamp":1498158570000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.hindawi.com\/journals\/drp\/2014\/240856\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":14,"alternative-id":["240856","240856"],"URL":"https:\/\/doi.org\/10.1155\/2014\/240856","relation":{},"ISSN":["1687-6105","1687-6113"],"issn-type":[{"value":"1687-6105","type":"print"},{"value":"1687-6113","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}